393 related articles for article (PubMed ID: 15608513)
1. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
Bachman KE; Park BH
Curr Opin Oncol; 2005 Jan; 17(1):49-54. PubMed ID: 15608513
[TBL] [Abstract][Full Text] [Related]
2. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
3. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma.
Gold LI; Parekh TV
Semin Reprod Endocrinol; 1999; 17(1):73-92. PubMed ID: 10406078
[TBL] [Abstract][Full Text] [Related]
4. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
5. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor activity of the TGF-beta pathway in human cancers.
Markowitz SD; Roberts AB
Cytokine Growth Factor Rev; 1996 Jun; 7(1):93-102. PubMed ID: 8864357
[TBL] [Abstract][Full Text] [Related]
7. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta signal transduction in epithelial cells.
Yue J; Mulder KM
Pharmacol Ther; 2001 Jul; 91(1):1-34. PubMed ID: 11707292
[TBL] [Abstract][Full Text] [Related]
9. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
Pardali K; Moustakas A
Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
[TBL] [Abstract][Full Text] [Related]
10. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
[TBL] [Abstract][Full Text] [Related]
11. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
Kim ES; Kim MS; Moon A
Int J Oncol; 2004 Nov; 25(5):1375-82. PubMed ID: 15492828
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta signaling and its targeted therapy in gastrointestinal cancers.
Gotovac JR; Fujihara KM; Phillips WA; Clemons NJ
Discov Med; 2018 Sep; 26(142):103-112. PubMed ID: 30399328
[TBL] [Abstract][Full Text] [Related]
15. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
Leu FP; Nandi M; Niu C
Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta signaling in cancer treatment.
Fabregat I; Fernando J; Mainez J; Sancho P
Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta signaling in epithelial cells.
Hartsough MT; Mulder KM
Pharmacol Ther; 1997; 75(1):21-41. PubMed ID: 9364579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
